Search results
Results from the WOW.Com Content Network
Many different medications can cause diarrhea. Antibiotics are one type. “Antibiotics may upset the delicate balance of intestinal flora and lead to diarrhea in certain people,” Dr. Ahmad says.
Conversely, hypertension or tachycardia can be treated with short-acting antihypertensive drugs such as nitroprusside or esmolol; longer acting drugs such as propranolol should be avoided as they may lead to hypotension and shock. [6] The cause of serotonin toxicity or accumulation is an important factor in determining the course of treatment.
As with other opiates, chronic use of codeine can cause physical dependence which can lead to severe withdrawal symptoms if a person suddenly stops the medication. Withdrawal symptoms include drug craving, runny nose, yawning, sweating, insomnia, weakness, stomach cramps, nausea, vomiting, diarrhea, muscle spasms, chills, irritability, and pain.
Signs and symptoms of mild cinchonism (which may occur from standard therapeutic doses of quinine) include flushed and sweaty skin, ringing of the ears (), blurred vision, impaired hearing, confusion, reversible high-frequency hearing loss, headache, abdominal pain, rashes, drug-induced lichenoid reaction (lichenoid photosensitivity), [1] vertigo, dizziness, nausea, vomiting and diarrhea.
Federal health officials are investigating overdoses and deaths involving the use of anti-diarrhea drugs. Skip to main content. News. 24/7 help. For premium support please call: 800 ...
Treatment for withdrawal usually involves weaning over a 3- to 21-day period if the infusion lasted for more than a week. [134] Symptoms include tremors, agitation, sleeplessness, inconsolable crying, diarrhea and sweating. In total, over fifty withdrawal symptoms are listed in this review article.
Partial agonists, like the anti-diarrhea drug loperamide and antagonists, like naloxegol for opioid-induced constipation, do not cross the blood–brain barrier, but can displace other opioids from binding to those receptors in the myenteric plexus. Because opioids are addictive and may result in fatal overdose, most are controlled substances.
The FDA rejected the combination drug in 2010 due to concerns over its safety. [23] In 2012 the FDA approved it after Vivus re-applied with further safety data. [ 24 ] At the time, one obesity specialist estimated that around 70% of his colleagues were already prescribing the combination off-label.